In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guests
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Resources Mentioned
In this episode of Obesity: A Disease, Dr. Suzanne Cuda, Executive Editor of the Obesity Medicine Association’s Obesity Pillars online journal, interviews Dr. Sarah...
In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity...
This episode is a segment focusing on obesity Telehealth services from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview...